Skip to main content
. 2015 Jan 16;115(6):2419–2452. doi: 10.1021/cr500452k

Figure 19.

Figure 19

Diseases of potential therapeutic application for a p300/CBP inhibitor. No p300/CBP inhibitor has yet made it into clinical trials, but the biology of p300/CBP action and documented effects of p300/CBP disruption lead us to hypothesize a beneficial therapeutic potential for a p300/CBP inhibitor in many diseases.